Dr. Lal Path Labs .profit decreased 12.88% in (Q1) FY 2020-21

Source

Team Infinities:

Dr. Lal Path Labs Limited. NSE Symbol:LALPATHLAB, BSE Security Code:539524 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.

Revenue Reported by Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
277.40 313.70 349.60
Calculated Revenue of Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
36.30 11.57%(Revenue Decrease) 72.20 20.65%(Revenue Decrease)

Revenue: Dr. Lal Path Labs Limited.'s financial report shows that the company's revenue decreased by 11.57% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.36.30 crores, as the company posted revenue of Rs.277.40 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.313.70 crores.
The result also shows that the company's revenue decreased by 20.65% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.72.20 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.349.60 crores.

Gross Margin(%) Reported by Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
71.47 76.14 78.76
Calculated Gross Margin(%) of Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
4.67 6.13%(GM Decrease) 7.29 9.26%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 6.13% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 4.67% GM decrease, as the company reported 71.47% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 76.14% GM.
The result also indicates, the company's GM decreased by 9.26% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 7.29% GM decrease; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 78.76% GM.

EBITDA Reported by Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
59.70 69.30 109.50
Calculated EBITDA of Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
9.60 13.85%(EBITDA Decrease) 49.80 45.48%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 13.85% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA decrease of Rs.9.60 crores, as the company posted EBITDA of Rs.59.70 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.69.30 crores.
The result also shows that the company's EBITDA decreased by 45.48% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA decrease of Rs.49.80 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.109.50 crores.

Profit and Loss Reported by Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
28.40(Profit ) 32.60(Profit ) 59.10(Profit )
Calculated Profit and Loss of Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
4.20 12.88%(Profit Decrease) 30.70 51.95%(Profit Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 12.88% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit decrease of Rs.4.20 crores, as the company posted profit of Rs.28.40 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.32.60 crores.
The result also shows that the company's profit decreased by 51.95% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit decrease of Rs.30.70 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.59.10 crores.

EPS Reported by Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
3.45 3.94 7.14
Calculated EPS of Dr. Lal Path Labs Limited. for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.49 12.44%(EPS Decrease) 3.69 51.68%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 12.44% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS decrease of Rs.0.49, as the company posted EPS of Rs.3.45; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.3.94.
The result also shows that the company's EPS decreased by 51.68% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS decrease of Rs.3.69; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.7.14.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.